Dr. Timothy Michael Ambrose, MD

Dr. Ambrose practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Ambrose's NPI, 1013237981, was assigned on June 2, 2010. Dr. Ambrose graduated from University of Pittsburgh School of Medicine in 2010. Dr. Ambrose holds Pennsylvania license MD451862.

Dr. Ambrose's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Dr. Ambrose's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Ambrose is also affiliated with Jefferson Torresdale Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Ambrose to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ambrose practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ambrose's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ambrose is licensed in Pennsylvania.

CMS data shows 294 Medicare services from Dr. Ambrose across 5 procedure codes in 2024, for 145 Medicare patients. Medicare paid $31,309 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 145 Medicare patients who saw Dr. Ambrose in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ambrose's median patient age at 56, with 46% women.

In 2024, Dr. Ambrose wrote 504 Medicare Part D claims for 58 patients. 91% of them were for generic drugs. CMS names the drug for 387 of them, across 12 drugs with 11 or more claims each, at $35,338 in total drug cost. In 2023, CMS named 354 claims across 14 drugs.

Dr. Ambrose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ambrose as offering telehealth.

Dmand AI links 4 papers to Dr. Ambrose, published from 2012 to 2021. Dr. Ambrose's most frequent co-authors are Anto Bagic, MD, Rodney D. Bell, MD and Caio Matias, MD.

Dr. Ambrose graduated from University of Pittsburgh School of Medicine in 2010.